Navigation Links
ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert;
Date:5/4/2009

Patients Experience Significant Improvement in Ocular Surface Disease and Quality of Life

LAWRENCEVILLE, N.J., May 4 /PRNewswire/ -- Aton Pharma, Inc. announced today that results from a large (n = 520) multi-center patient registry study of its Lacrisert(R) ophthalmic insert will be presented this week during the 2009 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), May 3-7, Ft. Lauderdale, FL, and later in the month at the 145th Annual Meeting of the American Ophthalmological Society (AOS), May 14 -17, Half Moon Bay, CA. Lacrisert (hydroxypropyl cellulose ophthalmic insert) is a preservative-free, once-daily*, sustained release prescription insert indicated for moderate to severe dry eye, that helps to retain moisture, stabilize the tear film, and lubricate the eye.

"This is the first major study of Lacrisert to be undertaken in more than two decades," stated Michael G. Wells, Chief Executive Officer of Aton Pharma. "Our commitment to expanding product availability and increasing physician awareness and knowledge of Lacrisert includes gathering of key efficacy data such as through this study."

The multicenter, 2-visit, open label, 4-week study was conducted to determine both physician and patient acceptability and ease of use of Lacrisert in adult patients with a history of dry eye syndrome. It was hypothesized that patients would experience improvements in their overall quality of life as well as in measures of dry eye signs and symptoms. A patient registry study is designed to examine a wide range of correlations and show predictive relationships, providing a rich resource of data to mine over time.

Association for Research in Vision and Ophthalmology (ARVO)

Bruce H. Koffler, M.D., will present data from the study in a poster at ARVO, "Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) Significantly Improves Symptoms of Dry Eye Synd
'/>"/>

SOURCE Aton Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PSA Screening Cuts Deaths by 20%, Says Worlds Largest Prostate Cancer Study
2. Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
3. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
4. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
5. CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
6. NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
7. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
8. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
9. Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End
10. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
11. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 LifeNet Health plans to enlarge ... 2015 to more than 160 people. The ... LifeNet Health,s innovative bio-implants, which are being made more ... be served. It also is a reflection of the ... "The growth and success of LifeNet Health is a ...
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
(Date:5/29/2015)... , May 29, 2015 Educating the ... the Association for the Advancement of Wound Care ... With support from AAWC,s corporate partners, the Association ... on the AAWC website at http://aawconline.org/education-for-the-generalist/ ... care pathway with links to various CME/CEU educational ...
Breaking Medicine Technology:LifeNet Health to add more than 160 jobs in 2015 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5The Association for the Advancement of Wound Care Educates the Public 2
... Findings from an international Phase 3 clinical trial of the ... and effective at restoring continence when worn up to 12 ... 87% of users rated the ability of the device to ... study results published in the British Journal of Nursing ...
... HONG KONG, Sept. 28, 2011 /PRNewswire-Asia-FirstCall/ -- Golden ... - 801.HK; 910801.TW), China,s leading integrated healthcare enterprise, today ... ownership in its NYSE-listed affiliate, China Cord Blood Corporation ... result of which the Group now owns 40.9% of ...
Cached Medicine Technology:Vitala™ Pouchless Continence Control Device Shown to be Safe and Effective for up to 12 Hours in Phase 3 Clinical Trial 2Vitala™ Pouchless Continence Control Device Shown to be Safe and Effective for up to 12 Hours in Phase 3 Clinical Trial 3Golden Meditech Increase Stake in NYSE-listed Affiliate - China Cord Blood Corporation to 40.9% 2
(Date:5/30/2015)... the Snail ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, Android, and ... conducted the app review and shared with viewers how this ... Interactive mobile games for children have become quite popular these ... playing are doing much for their intellectual development. However, there’s ...
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a ... hanging signs ; making what was formerly an elite ... ceiling rigging points at a usual height of 16’-20’ are ... These signs are very unique and more visible than the ... and dismantle labor and rigging the costs far outweigh the ...
(Date:5/29/2015)... What does community do? , According to ... together to plant gardens, to teach young people, to ... critical issues. Community invites everyone to help improve lives ... Community Does" was commissioned by The Denver Foundation, the ... during the foundation’s Annual Celebration in May. At just ...
(Date:5/29/2015)... Cincinnati, Ohio (PRWEB) May 29, 2015 ... Proven Experience to Cincinnati , The Department of Veterans ... John A. Gennaro as the new director of the ... of health care to more than 43,000 unique Veterans ... , With over 2,000 staff, CVAMC is a two-division ...
(Date:5/29/2015)... May 29, 2015 Dot Hill can mark one ... resident of Lake Prince Woods retirement community is the ... Virginia Beach, Virginia. , “It was great fun!”, she exclaimed. ... didn’t want me to so they thought this would be ok.” ... into a vertical wind tunnel,” she described. “I don’t remember ...
Breaking Medicine News(10 mins):Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2Health News:Indoor Skydiving Brings Thrills to Seniors 2
... Research shows canines can count, learn words , MONDAY, ... the beloved family dog is really a toddler with ... developmental abilities equivalent to a human 2-year-old," said dog ... canine research developments at the American Psychological Association annual ...
... , The National Comprehensive Cancer Network (NCCN) recently ... the results of the recent ERSPC trial that assessed the ... screening does save lives when performed intelligently in men at ... FORT WASHINGTON, Pa., Aug. 10 Prostate-Specific Antigen (PSA) ...
... AlphaRx Inc. (OTC BB:ALRX.OB - News), an emerging ... develop novel formulations of drugs, is pleased to ... patent in China for its topical platform technology ... The platform is an integral part of the ...
... , , NEW YORK, ... CRE ) ("Care" or the "Company"), a real estate investment and finance ... today reported financial results for the second quarter ended June 30, 2009. ... GAAP of $0.5 million, or $0.03 per basic and diluted share. ...
... ROCHESTER, N.Y., Aug. 10 Your sleeping problems might be ... (FM), and Chronic Fatigue Syndrome (CFS). But it can also be ... , , Recent studies show that chronic infection ... by Professor Mark Opp from the University of Michigan Medical School ...
... Aug. 10 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex") (Nasdaq: ... Western,healthcare products and services in the People,s Republic of ... exclusive, multi-year distribution,agreements for China with Biotest AG and ... based in Dreieich, Germany (SDAX: BIO3), specializes in,innovative hematology ...
Cached Medicine News:Health News:Dogs and 2-Year-Olds on Same Mental Plane 2Health News:Dogs and 2-Year-Olds on Same Mental Plane 3Health News:NCCN Stresses Importance of PSA Testing in High-Risk Men 2Health News:NCCN Stresses Importance of PSA Testing in High-Risk Men 3Health News:NCCN Stresses Importance of PSA Testing in High-Risk Men 4Health News:NCCN Stresses Importance of PSA Testing in High-Risk Men 5Health News:AlphaRx Receives China Patent on Its Drug Delivery Platform 2Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 2Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 3Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 4Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 5Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 6Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 7Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 8Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 9Health News:Surprise! Better Sleep with Gene-Eden(R), an Antiviral Supplement 2Health News:Surprise! Better Sleep with Gene-Eden(R), an Antiviral Supplement 3Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 2Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 3Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 4
Papavero-caspar specula for trans-sphenoidal hypophysectomy....
Landolt hypophysectomie instrument, spoon, bayonet-shaped, flexible....
Fahlbusch hypophysectomie instrument, spoon, bayonet-shaped, malleable....
Cushing pituitary scoop, malleable, silver-plated....
Medicine Products: